Bioequivalence Study of Pravastatin Sodium Tablets 80 mg Under Fed Conditions
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
This is a single Dose Two-Way Crossover Fed Bioequivalence Study of Pravastatin 80 mg Tablets
of Dr.Reddy's Laboratories Limited with Pravachol 80mg, Bristol Myers Squibb in Healthy
Volunteers.